<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The outcome of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> varies depending on ethnic origin </plain></SENT>
<SENT sid="1" pm="."><plain>Egyptian colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> is surprisingly young-age disease with high proportion of rectal and advanced stage <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We characterized 69 <z:hpo ids='HP_0003745'>sporadic</z:hpo> Egyptian <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> for promoter methylation at 24 tumor suppressor genes, microsatellite instability, and expression of mismatch repair, p53, and β-catenin proteins </plain></SENT>
<SENT sid="3" pm="."><plain>Data were compared with 80 Western colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> of <z:hpo ids='HP_0003745'>sporadic</z:hpo> and familial origin from Finland </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Egyptian colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> showed significantly higher methylation of the microsatellite stable (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> as reflected by the average number of methylated genes per case (P = 0.00002) and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene methylator phenotype (TSGMP), defined here as methylation of ≥ 5 genes, (P = 0.0001) compared with the <z:hpo ids='HP_0003745'>sporadic</z:hpo> Western <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The TSGMP was associated with advanced stage in the Egyptian <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (P = 0.0016) </plain></SENT>
<SENT sid="6" pm="."><plain>Four genes were differentially methylated between Egyptian and Western cases, of which the association of CDKN2B/p15 methylation with Egyptian origin was outstanding (P = 4.83 E-10) </plain></SENT>
<SENT sid="7" pm="."><plain>Egyptian <z:mp ids='MP_0002038'>carcinoma</z:mp> also showed significantly lower frequency of nuclear β-catenin localization than the <z:hpo ids='HP_0003745'>sporadic</z:hpo> Western <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (P = 0.00006) but similar to that of the familial Western subset designated as familial <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> type X </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: We show novel pathway in colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> marked by high methylation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, remarkable CDKN2B/p15 methylation, and low frequency of Wnt signaling activation </plain></SENT>
<SENT sid="9" pm="."><plain>IMPACT: Our findings highlight the possible effect of environmental exposures in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> through DNA methylation and should have applications in prevention, molecular diagnosis, prognosis, and treatment </plain></SENT>
</text></document>